Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Rapid Fingertip Blood Test Accurately Diagnoses Tuberculosis in Children

By LabMedica International staff writers
Posted on 01 Nov 2023

Every year, tuberculosis claims the lives of approximately 240,000 children globally, making it one of the leading causes of death for kids under five. More...

A key issue contributing to these numbers is the frequent failure to diagnose the disease correctly or in a timely manner, especially in resource-limited settings. Traditional methods for diagnosing tuberculosis generally rely on microbiological analysis of sputum, or mucus collected from the lower airways. This is a challenge in children, who often have a low bacterial count in their sputum and show nonspecific symptoms. Now, a new diagnostic tool makes it easier to diagnose tuberculosis in children by requiring just a fingertip blood sample.

An international research consortium led by medical scientists at LMU University Hospital Munich (Munich, Germany) conducted extensive testing of this new diagnostic method in a large study spanning five countries. The tool operates on the basis of the activity of three specific genes measurable in capillary blood. Using an innovative semi-automatic system, healthcare providers can identify a transcriptomic signature for these genes, which aids in diagnosing tuberculosis. A significant advantage of this test is its convenience: the blood sample can be taken effortlessly from a fingertip, and the results are available in just over an hour. This is much faster than most other tests, which often require sending samples to specialized labs for analysis.

The new tool was evaluated during the RaPaed-TB tuberculosis study, conducted in collaboration with partners in South Africa, Mozambique, Tanzania, Malawi, and India. The study involved 975 children under the age of 15 who were suspected of having tuberculosis. To assess the test's accuracy, the children's tuberculosis status was also examined using a standardized reference test based on sputum analysis and bacterial cultures. Given that the reference signature for the new tool was mostly derived from adult samples, the researchers believe that the accuracy of the test can be enhanced further by fine-tuning the signature calculation for children.

“The results were encouraging,” said LMU medical scientist Laura Olbrich. “Compared to detection in culture, the test identified almost 60 percent of children with tuberculosis, with 90-percent specificity. This makes the test comparable with or better than all other tests that work with biomarkers. The bacterial culture is always the reference because it yields the most stable results. But it takes up to eight weeks and is often not available where children with tuberculosis present.”

Related Links:
LMU University Hospital Munich 


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.